Department of Internal Medicine, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Diabetes Technol Ther. 2011 Jul;13(7):731-6. doi: 10.1089/dia.2011.0013. Epub 2011 Apr 19.
The purpose of this study was to examine future acceptance of an artificial pancreas (AP) and its perceived usefulness, ease of use, and trust in the device.
A questionnaire, based on the Technology Acceptance Model, was developed to examine future acceptance with its determinants and intention to use the AP. One hundred thirty-two patients with diabetes type 1 treated with insulin pump therapy completed the questionnaire. Using factor analysis and reliability analysis, the number of items was reduced from 34 to 15.
The response rate was 66%. The subjects had a mean age of 43 years, and 34% were male. Almost 75% had the intention to use an AP. There were high scores on perceived usefulness (expected improvement of glucose control: 35.6% moderately agreed and 53% strongly agreed), perceived ease of use (expectation that the AP can be easily handled: 33.3% moderately agreed and 53.8% strongly agreed), and trust (administration of correct insulin dose and reliability of glucose measurement: 40.9% and 38.9% moderately agreed, whereas 32.6% and 28.2% strongly agreed, respectively).
A newly developed questionnaire examining the acceptance of an AP indicated that most patients with continuous subcutaneous insulin infusion-treated type 1 diabetes have the intention to use an AP system and have a positive attitude toward perceived usefulness, ease of use, and trust.
本研究旨在探讨对人工胰腺（AP）的未来接受程度及其感知有用性、易用性和对设备的信任度。
基于技术接受模型开发了一份问卷，以检查未来的接受程度及其决定因素和使用 AP 的意图。132 名接受胰岛素泵治疗的 1 型糖尿病患者完成了问卷。通过因子分析和可靠性分析，将项目数量从 34 项减少到 15 项。
应答率为 66%。受试者的平均年龄为 43 岁，34%为男性。近 75%的人有使用 AP 的意愿。感知有用性（预期改善血糖控制：35.6%中度同意，53%强烈同意）、感知易用性（期望 AP 易于操作：33.3%中度同意，53.8%强烈同意）和信任（给予正确的胰岛素剂量和血糖测量的可靠性：40.9%和 38.9%中度同意，而 32.6%和 28.2%强烈同意）得分较高。
一份新开发的问卷调查了对 AP 的接受程度，表明大多数接受持续皮下胰岛素输注治疗的 1 型糖尿病患者有使用 AP 系统的意愿，并对感知有用性、易用性和信任持积极态度。
